Fig. 2From: COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cellsThe effect of 48 h treatment with COXIBs on A-172 (panel a), T98G (panel b) and U-138 MG (panel c) cell lines. Panel d - the cytotoxicity of PKF118–310. Data presented as mean values ± SEM from three independent experimentsBack to article page